199 related articles for article (PubMed ID: 23382965)
61. Astragalus extract inhibits proliferation but enhances apoptosis in gastric cancer.
Wang Z; Dong L; Zhen Y; Wang Y; Qi D; Xu A; Meng X; Li W
Pak J Pharm Sci; 2016 Sep; 29(5):1473-1482. PubMed ID: 27731799
[TBL] [Abstract][Full Text] [Related]
62. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid.
Li JJ; Tang Q; Li Y; Hu BR; Ming ZY; Fu Q; Qian JQ; Xiang JZ
Acta Pharmacol Sin; 2006 Aug; 27(8):1078-84. PubMed ID: 16867262
[TBL] [Abstract][Full Text] [Related]
63. [Preliminary study on the arsenic trioxide-induced NB4 cell apoptosis and its molecular mechanisms].
Chen G; Zhu J; Shi X; Zhong H; Liu W; Jin X; Tang W; Li X; Ni J; Xiong S; Shen Z; Ma J; Zhang P; Zhang T; Claude G; Chen S; Chen L; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 1997 Jan; 18(1):25-8. PubMed ID: 15622746
[TBL] [Abstract][Full Text] [Related]
64. Bcl-2 antisense oligodeoxynucleotide increases the sensitivity of leukemic cells to arsenic trioxide.
Zhang Y; Shen WL
Cell Biol Int; 2003; 27(12):953-8. PubMed ID: 14642526
[TBL] [Abstract][Full Text] [Related]
65. BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma.
Morales AA; Gutman D; Lee KP; Boise LH
Blood; 2008 May; 111(10):5152-62. PubMed ID: 18354037
[TBL] [Abstract][Full Text] [Related]
66. Possible involvement of persistent activity of the mammalian target of rapamycin pathway in the cisplatin resistance of AFP-producing gastric cancer cells.
Kamata S; Kishimoto T; Kobayashi S; Miyazaki M; Ishikura H
Cancer Biol Ther; 2007 Jul; 6(7):1036-43. PubMed ID: 17568186
[TBL] [Abstract][Full Text] [Related]
67. Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells.
Chow SK; Chan JY; Fung KP
J Cell Biochem; 2004 Sep; 93(1):173-87. PubMed ID: 15352174
[TBL] [Abstract][Full Text] [Related]
68. [Study on the mechanisms of telomerase regulations during apoptosis of the human MDS-RAEB cell line MUTZ-1 cells induced by arsenic trioxide].
Tong HY; Jin J; Xu WL; Qian WB; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):615-9. PubMed ID: 16129045
[TBL] [Abstract][Full Text] [Related]
69. Therapeutic effect of arsenic trioxide (As2O3) on cervical cancer in vitro and in vivo through apoptosis induction.
Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
Cancer Biol Ther; 2007 Apr; 6(4):580-6. PubMed ID: 17374990
[TBL] [Abstract][Full Text] [Related]
70. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y
Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001
[TBL] [Abstract][Full Text] [Related]
71. Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells.
Song MQ; Zhu JS; Chen JL; Wang L; Da W; Zhu L; Zhang WP
World J Gastroenterol; 2007 Mar; 13(12):1788-93. PubMed ID: 17465467
[TBL] [Abstract][Full Text] [Related]
72. Antitumor effect of arsenic trioxide in human K562 and K562/ADM cells by autophagy.
Cheng J; Wei HL; Chen J; Xie B
Toxicol Mech Methods; 2012 Sep; 22(7):512-9. PubMed ID: 22519831
[TBL] [Abstract][Full Text] [Related]
73. Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs.
Meister MT; Boedicker C; Graab U; Hugle M; Hahn H; Klingebiel T; Fulda S
Cancer Lett; 2016 Oct; 381(2):287-95. PubMed ID: 27521572
[TBL] [Abstract][Full Text] [Related]
74. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
[TBL] [Abstract][Full Text] [Related]
75. Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer.
Xiao YF; Liu SX; Wu DD; Chen X; Ren LF
World J Gastroenterol; 2006 Sep; 12(36):5780-6. PubMed ID: 17007042
[TBL] [Abstract][Full Text] [Related]
76. Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.
Cui L; Gao B; Cao Z; Chen X; Zhang S; Zhang W
Mol Med Rep; 2016 Mar; 13(3):2032-8. PubMed ID: 26781180
[TBL] [Abstract][Full Text] [Related]
77. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
[TBL] [Abstract][Full Text] [Related]
78. Arsenic trioxide: acute promyelocytic leukemia and beyond.
Bachleitner-Hofmann T; Kees M; Gisslinger H
Leuk Lymphoma; 2002 Aug; 43(8):1535-40. PubMed ID: 12400595
[TBL] [Abstract][Full Text] [Related]
79. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
[TBL] [Abstract][Full Text] [Related]
80. Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model.
Zhuang Q; Hong F; Shen A; Zheng L; Zeng J; Lin W; Chen Y; Sferra TJ; Hong Z; Peng J
Int J Oncol; 2012 May; 40(5):1569-74. PubMed ID: 22218594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
